BioWorld MedTech

Aug. 16, 2018

Capillary Biomedical closes $2.9M seed funding

Irvine, Calif.-based Capillary Biomedical Inc. (CapBio), which is looking to combat failure points with current infusion sets, raised $2.9 million in a series seed funding led by the Cove Fund. Read More

Device makers wary of FDA's view of economics of HUDs

FDA gives first-time nod to consumer app for preventing pregnancy

Nanotech opens potential for small, accurate, cheap and fast portable diagnostics

Mutation burden predicts benefit of PD-1-treated NSCLC

Appointments and advancements

Financings

Daily M&A

Other news to note

Product briefs

Regulatory front

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 12, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026